Author Correction: A multicenter study of asymmetric and symmetric dimethylarginine as predictors of mortality risk in hospitalized COVID-19 patients

• Juliane Hannemann,
• Anne Zink,
• Yoana Mileva,
• Paul Balfanz,
• Edgar Dahl,
• Sonja Volland,
• Thomas Illig,
• Edzard Schwedhelm,
• Florian Kurth,
• Alexandra Stege,
• Martin Aepfelbacher,
• Armin Hofmann,
• Rainer Böger

Affiliations

Juliane Hannemann

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf

Anne Zink

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf

Yoana Mileva

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf

Paul Balfanz

Department of Cardiology, Angiology and Intensive Care Medicine, Medical Clinic I, University Hospital Aachen

Edgar Dahl

Institute of Pathology and Central Biobank, University Hospital Aachen

Sonja Volland

Hannover Unifed Biobank, Medizinische Hochschule Hannover

Thomas Illig

Hannover Unifed Biobank, Medizinische Hochschule Hannover

Edzard Schwedhelm

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf

Florian Kurth

Department of Infectious Diseases and Critical Care Medicine, Charité Universitätsmedizin Berlin

Alexandra Stege

Central Biobank Charité, Charité Universitätsmedizin Berlin

Martin Aepfelbacher

Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf

Armin Hofmann

Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf

Rainer Böger

Institute of Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf